Related content

Personalized Medicine of Alcohol Addiction: Pharmacogenomics and Beyond

By  

Current Pharmaceutical Biotechnology, Vol. 18, Iss. 3, 2017-04 ,pp. : 221-230

Bentham Science Publishers

Access to resources Recommend Favorite

Towards a balanced value business model for personalized medicine: an outlook

By Koelsch Christof   Przewrocka Joanna   Keeling Peter  

Pharmacogenomics, Vol. 14, Iss. 1, 2013-01 ,pp. : 89-102

Future Medicine

Access to resources Recommend Favorite

H2020 and Beyond: Skip Discrepancy between Theory and Practice of Personalized Medicine. A Position Paper by the Italian Society of Personalized Medicine

By  

Current Pharmaceutical Biotechnology, Vol. 17, Iss. 10, 2016-08 ,pp. : 926-929

Bentham Science Publishers

Access to resources Recommend Favorite

Personalized Medicine Beyond Genomics: New Technologies, Global Health Diplomacy and Anticipatory Governance

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 7, Iss. 4, 2009-12 ,pp. : 225-230

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (Moving Beyond Our Mutual Ignorance. Or, How would Engaging the Public Benefit the Personalized Medicine Community?)

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 9, Iss. 2, 2011-06 ,pp. : 76-79

Bentham Science Publishers

Access to resources Recommend Favorite